Loading...
XNAS
PODD
Market cap10bUSD
Jul 10, Last price  
161.28USD
1D
0.53%
1Q
-19.62%
Jan 2017
320.09%
IPO
924.53%
Name

Insulet Corp

Chart & Performance

D1W1MN
XNAS:PODD chart
P/E
45.21
P/S
4.13
EPS
3.57
Div Yield, %
—
Shrs. gr., 5y
1.74%
Rev. gr., 5y
24.53%
Revenues
2.71b
+30.73%
3,663,00013,372,00036,059,00066,032,00096,966,000152,255,000211,369,000247,084,000288,720,000263,893,000366,989,000463,768,000563,823,000738,200,000904,400,0001,098,800,0001,305,300,0001,697,100,0002,071,600,0002,708,100,000
Net income
247m
-40.93%
-35,950,000-53,539,000-92,791,000-79,541,000-61,159,000-57,170,000-51,867,000-44,974,000-51,500,000-73,520,000-28,879,000-26,831,0003,292,00011,600,0006,800,00016,800,0004,600,000206,300,000418,300,000247,100,000
CFO
569m
+32.30%
-31,820,000-50,372,000-82,611,000-49,323,000-35,625,000-25,452,000-29,059,0003,348,0008,920,000-12,552,00015,911,00041,300,00035,900,00098,400,00084,000,000-68,100,000119,000,000145,700,000430,300,000569,300,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
URL
https://www.omnipod.com/
IPO date
May 15, 2007
Employees
2,600
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT